TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Domestic Violence Enhanced Home Visitation Program - DOVE
Brief Summary: DOVE Home Visit Program is a brochure based intervention delivery by public health nurses which aims to prevent and reduce intimate partner violence against pregnant and postpartum women and their infants.

The purpose of the study is to test the effect of home visits on reducing domestic violence and improving the lives of pregnant women and their children.


Options:
A: Arm Label: Control - VSLA; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Control - Mental Health; Type: OTHER; Interventions: Behavioral: Treatment as usual | Arm Label: Voluntary Savings/Loans Assoc; Type: EXPERIMENTAL; Interventions: Behavioral: Voluntary Savings/Loans Assoc | Arm Label: Cognitive Processing Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Processing Therapy | Intervention Type: BEHAVIORAL; Name: Treatment as usual; Assigned to Arm(s): Control - Mental Health | Intervention Type: BEHAVIORAL; Name: Voluntary Savings/Loans Assoc; Assigned to Arm(s): Voluntary Savings/Loans Assoc | Intervention Type: BEHAVIORAL; Name: Cognitive Processing Therapy; Assigned to Arm(s): Cognitive Processing Therapy
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Public Health Nurse Home Visit | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Intimate Partner Violence (IPV) Protocol | Intervention Type: BEHAVIORAL; Name: Public Health Nurse Home Visit; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Intimate Partner Violence (IPV) Protocol; Assigned to Arm(s): 2
C: Arm Label: Internet Based Safety Decision Aid; Type: EXPERIMENTAL; Interventions: Behavioral: Internet-based safety decision aid | Arm Label: Control Website; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care Safety Plan | Intervention Type: BEHAVIORAL; Name: Internet-based safety decision aid; Assigned to Arm(s): Internet Based Safety Decision Aid | Intervention Type: BEHAVIORAL; Name: Usual Care Safety Plan; Assigned to Arm(s): Control Website
D: Arm Label: Mentor Mothers Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Peer support and mentoring | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Peer support and mentoring; Assigned to Arm(s): Mentor Mothers Intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Domestic Violence Enhanced Home Visitation Program - DOVE
Brief Summary: DOVE Home Visit Program is a brochure based intervention delivery by public health nurses which aims to prevent and reduce intimate partner violence against pregnant and postpartum women and their infants.

The purpose of the study is to test the effect of home visits on reducing domestic violence and improving the lives of pregnant women and their children.


Options:
A: Arm Label: Model Care (SEEK); Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced pediatric primary care | Arm Label: Standard pediatric primary care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard pediatric primary care | Intervention Type: BEHAVIORAL; Name: Enhanced pediatric primary care; Assigned to Arm(s): Model Care (SEEK) | Intervention Type: BEHAVIORAL; Name: Standard pediatric primary care; Assigned to Arm(s): Standard pediatric primary care
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Public Health Nurse Home Visit | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Intimate Partner Violence (IPV) Protocol | Intervention Type: BEHAVIORAL; Name: Public Health Nurse Home Visit; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Intimate Partner Violence (IPV) Protocol; Assigned to Arm(s): 2
C: Arm Label: Intervention arm; Type: EXPERIMENTAL; Interventions: Behavioral: The SHARE Project | Arm Label: Control arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: The SHARE Project; Assigned to Arm(s): Intervention arm
D: Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Domestic Violence Enhanced Home Visitation Program - DOVE
Brief Summary: DOVE Home Visit Program is a brochure based intervention delivery by public health nurses which aims to prevent and reduce intimate partner violence against pregnant and postpartum women and their infants.

The purpose of the study is to test the effect of home visits on reducing domestic violence and improving the lives of pregnant women and their children.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Public Health Nurse Home Visit | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Intimate Partner Violence (IPV) Protocol | Intervention Type: BEHAVIORAL; Name: Public Health Nurse Home Visit; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Intimate Partner Violence (IPV) Protocol; Assigned to Arm(s): 2
B: Arm Label: Referral Card Only; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Integrated Screening; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated Screening | Intervention Type: BEHAVIORAL; Name: Integrated Screening; Assigned to Arm(s): Integrated Screening
C: Arm Label: NFP + IPV intervention; Type: EXPERIMENTAL; Interventions: Behavioral: NFP + IPV intervention | Arm Label: NFP (standard care); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: NFP + IPV intervention; Assigned to Arm(s): NFP + IPV intervention
D: Arm Label: Clinics trained in brief intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Family Planning-based Partner Violence Intervention | Arm Label: Control sites providing standard of care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Family Planning-based Partner Violence Intervention; Assigned to Arm(s): Clinics trained in brief intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Domestic Violence Enhanced Home Visitation Program - DOVE
Brief Summary: DOVE Home Visit Program is a brochure based intervention delivery by public health nurses which aims to prevent and reduce intimate partner violence against pregnant and postpartum women and their infants.

The purpose of the study is to test the effect of home visits on reducing domestic violence and improving the lives of pregnant women and their children.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Public Health Nurse Home Visit | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Intimate Partner Violence (IPV) Protocol | Intervention Type: BEHAVIORAL; Name: Public Health Nurse Home Visit; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Intimate Partner Violence (IPV) Protocol; Assigned to Arm(s): 2
B: Arm Label: Primary Care for DILs; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Primary care for Daughters-in-Law | Arm Label: Standard Care plus Dil Mil Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: The Dil Mil Intervention | Intervention Type: BEHAVIORAL; Name: Primary care for Daughters-in-Law; Assigned to Arm(s): Primary Care for DILs | Intervention Type: BEHAVIORAL; Name: The Dil Mil Intervention; Assigned to Arm(s): Standard Care plus Dil Mil Intervention
C: Intervention Type: BEHAVIORAL; Name: Home Visiting; Assigned to Arm(s): N/A
D: Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Psychopharmacology of Psilocybin in Cancer Patients
Brief Summary: This research is being done to study the psychological effects of psilocybin in cancer patients. Psilocybin is a naturally occurring substance found in some mushrooms that some cultures have used for centuries in religious practices.


Options:
A: Arm Label: Low Dose First, High Dose Second; Type: EXPERIMENTAL; Interventions: Drug: psilocybin | Arm Label: High Dose First, Low Dose Second; Type: EXPERIMENTAL; Interventions: Drug: psilocybin | Intervention Type: DRUG; Name: psilocybin; Assigned to Arm(s): High Dose First, Low Dose Second, Low Dose First, High Dose Second
B: Arm Label: Psilocybin; Type: EXPERIMENTAL; Interventions: Drug: Psilocybin, Drug: Niacin | Arm Label: Niacin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Psilocybin, Drug: Niacin | Intervention Type: DRUG; Name: Psilocybin; Assigned to Arm(s): Niacin, Psilocybin | Intervention Type: DRUG; Name: Niacin; Assigned to Arm(s): Niacin, Psilocybin
C: Arm Label: Methylphenidate add on to Mirtazapine; Type: EXPERIMENTAL; Interventions: Drug: Methylphenidate | Arm Label: Placebo add on to Mirtazapine; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Methylphenidate; Assigned to Arm(s): Methylphenidate add on to Mirtazapine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo add on to Mirtazapine
D: Arm Label: Arm I - Placebo; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Placebo Powder, Drug: Placebo Pill | Arm Label: Arm II - Soy; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: oral soy protein/isoflavones powder, Drug: Placebo Pill | Arm Label: Arm III - Venlafaxine; Type: EXPERIMENTAL; Interventions: Drug: Venlafaxine, Dietary Supplement: Placebo Powder | Arm Label: Arm IV - Soy + Venlafaxine; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: oral soy protein/isoflavones powder, Drug: Venlafaxine | Intervention Type: DIETARY_SUPPLEMENT; Name: oral soy protein/isoflavones powder; Assigned to Arm(s): Arm II - Soy, Arm IV - Soy + Venlafaxine | Intervention Type: DRUG; Name: Venlafaxine; Assigned to Arm(s): Arm III - Venlafaxine, Arm IV - Soy + Venlafaxine | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo Powder; Assigned to Arm(s): Arm I - Placebo, Arm III - Venlafaxine | Intervention Type: DRUG; Name: Placebo Pill; Assigned to Arm(s): Arm I - Placebo, Arm II - Soy

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pilot Tolerance and Bone Status of Healthy, Term Infants Fed Infant Formulas
Brief Summary: To compare the tolerance and early bone status of healthy, term infants fed formulas during the first three months of life.


Options:
A: Arm Label: Protein formula; Type: EXPERIMENTAL; Interventions: Other: Alternate protein infant formula | Arm Label: Standard infant formula; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard infant formula | Intervention Type: OTHER; Name: Alternate protein infant formula; Assigned to Arm(s): Protein formula | Intervention Type: OTHER; Name: Standard infant formula; Assigned to Arm(s): Standard infant formula
B: Arm Label: Study Formula (SF); Type: EXPERIMENTAL; Interventions: Other: Study Formula (SF), Other: Comparator Formula (CF) | Arm Label: Comparator Formula (CF); Type: ACTIVE_COMPARATOR; Interventions: Other: Study Formula (SF), Other: Comparator Formula (CF) | Arm Label: Human Milk Reference Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Study Formula (SF); Assigned to Arm(s): Comparator Formula (CF), Study Formula (SF) | Intervention Type: OTHER; Name: Comparator Formula (CF); Assigned to Arm(s): Comparator Formula (CF), Study Formula (SF)
C: Arm Label: Standard infant formula; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Standard infant formula | Arm Label: Protein reduced formula; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Protein reduced alpha-lactalbumin formula, with higher levels of alpha-lactalbumin | Arm Label: Breast-feeding; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Standard infant formula; Assigned to Arm(s): Standard infant formula | Intervention Type: DIETARY_SUPPLEMENT; Name: Protein reduced alpha-lactalbumin formula, with higher levels of alpha-lactalbumin; Assigned to Arm(s): Protein reduced formula
D: Arm Label: Experimental Group; Type: EXPERIMENTAL; Interventions: Other: Modified infant formula | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard infant formula | Arm Label: Breast-fed Reference Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Modified infant formula; Assigned to Arm(s): Experimental Group | Intervention Type: OTHER; Name: Standard infant formula; Assigned to Arm(s): Control Group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Reduced in-Hospital Mortality After Improved Management of Patients Hospitalised With Malaria. A Randomised Trial
Brief Summary: The study intend to evaluate whether the use of standardised malaria case management protocol plus financial incentives added to the availability of free drugs reduce the case-fatality at the paediatric ward.


Options:
A: Arm Label: No incentive; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: KES financial incentive 1; Type: EXPERIMENTAL; Interventions: Behavioral: Financial incentive | Arm Label: KES financial incentive 2; Type: EXPERIMENTAL; Interventions: Behavioral: Financial incentive | Arm Label: KES financial incentive 3; Type: EXPERIMENTAL; Interventions: Behavioral: Financial incentive | Arm Label: KES financial incentive 4; Type: EXPERIMENTAL; Interventions: Behavioral: Financial incentive | Intervention Type: BEHAVIORAL; Name: Financial incentive; Assigned to Arm(s): KES financial incentive 1, KES financial incentive 2, KES financial incentive 3, KES financial incentive 4
B: Arm Label: Comparison Arm; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Active Intervention 1; Type: EXPERIMENTAL; Interventions: Behavioral: Active Arm 1 | Arm Label: Active Intervention 2; Type: EXPERIMENTAL; Interventions: Behavioral: Active Arm 2 | Intervention Type: BEHAVIORAL; Name: Active Arm 1; Assigned to Arm(s): Active Intervention 1 | Intervention Type: BEHAVIORAL; Name: Active Arm 2; Assigned to Arm(s): Active Intervention 2
C: Arm Label: Intervention arm; Type: EXPERIMENTAL; Interventions: Behavioral: Information Communication Technology Continuum of Care Service | Arm Label: Control Arm; Type: ACTIVE_COMPARATOR; Interventions: Other: Control Condition | Intervention Type: BEHAVIORAL; Name: Information Communication Technology Continuum of Care Service; Assigned to Arm(s): Intervention arm | Intervention Type: OTHER; Name: Control Condition; Assigned to Arm(s): Control Arm
D: Intervention Type: BEHAVIORAL; Name: Guideline adherence and financial incentive; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Particulate Reduction Education in City Homes (PREACH)
Brief Summary: The purpose of this study is to conduct a randomized controlled trial of the efficacy of a combination of HEPA room air cleaners plus an ETS reduction behavior training as compared to either HEPA air cleaners plus standard asthma education or delayed HEPA air cleaners and standard asthma education (control group).


Options:
A: Intervention Type: BEHAVIORAL; Name: smoking cessation intervention; Assigned to Arm(s): N/A | Intervention Type: OTHER; Name: cancer prevention; Assigned to Arm(s): N/A | Intervention Type: OTHER; Name: counseling intervention; Assigned to Arm(s): N/A | Intervention Type: OTHER; Name: educational intervention; Assigned to Arm(s): N/A | Intervention Type: OTHER; Name: laboratory biomarker analysis; Assigned to Arm(s): N/A | Intervention Type: OTHER; Name: questionnaire administration; Assigned to Arm(s): N/A | Intervention Type: OTHER; Name: survey administration; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: study of high risk factors; Assigned to Arm(s): N/A
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Educational print materials and a coaching call | Intervention Type: BEHAVIORAL; Name: Educational print materials and a coaching call; Assigned to Arm(s): Intervention
C: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: bio-chemical feedback and expert system intervention ETS | Intervention Type: BEHAVIORAL; Name: bio-chemical feedback and expert system intervention ETS; Assigned to Arm(s): 2
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Health Coach and HEPA Air cleaners | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Health Coach and HEPA air cleaners | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Health Coach and HEPA air cleaners | Intervention Type: BEHAVIORAL; Name: Health Coach and HEPA Air cleaners; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Health Coach and HEPA air cleaners; Assigned to Arm(s): 1, 2, 3

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Double-blinded Randomized Controlled Trial With Indomethacin Versus Placebo in Women With Preterm Premature Rupture of Membranes (PPROM) Between 24 and 32 Weeks Gestation
Brief Summary: The purpose of this study is to determine if the short term use of indomethacin will reduce the number of women delivering within 48 hours when given to women with preterm premature rupture of membranes (PPROM) between 24- 32 weeks of gestation. We hypothesize that indomethacin's anti-inflammatory and tocolytic action will reduce the number of women delivering within 48 hours when given to women with PPROM between 24-32 weeks of gestation.


Options:
A: Intervention Type: DRUG; Name: indomethacin; Assigned to Arm(s): N/A
B: Arm Label: Nifedipine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nifedipine | Arm Label: Nifedipine plus Indomethacin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nifedipine, Drug: Indomethacin | Intervention Type: DRUG; Name: Nifedipine; Assigned to Arm(s): Nifedipine, Nifedipine plus Indomethacin | Intervention Type: DRUG; Name: Indomethacin; Assigned to Arm(s): Nifedipine plus Indomethacin
C: Arm Label: Atosiban; Type: EXPERIMENTAL; Interventions: Drug: Atosiban | Arm Label: Nifedipine; Type: EXPERIMENTAL; Interventions: Drug: Nifedipine | Intervention Type: DRUG; Name: Atosiban; Assigned to Arm(s): Atosiban | Intervention Type: DRUG; Name: Nifedipine; Assigned to Arm(s): Nifedipine
D: Arm Label: Nifedipine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nifedipine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo of Nifedipine | Intervention Type: DRUG; Name: Nifedipine; Assigned to Arm(s): Nifedipine | Intervention Type: DRUG; Name: Placebo of Nifedipine; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Adapting Web-based Instruction to Learner Baseline Knowledge: A Randomized Controlled Trial
Brief Summary: The purpose of this study is to compare an adaptive Web-based learning system to a non-adaptive system for teaching physicians-in-training about ambulatory medicine.


Options:
A: Intervention Type: BEHAVIORAL; Name: knowledge-adaptive Web-based instruction; Assigned to Arm(s): N/A
B: Arm Label: E-learning program; Type: N/A; Interventions: Other: E-learning program | Arm Label: control group; Type: N/A; Interventions: N/A | Intervention Type: OTHER; Name: E-learning program; Assigned to Arm(s): E-learning program
C: Arm Label: OSS Phase 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Training and supervision, Behavioral: Integrated Management of Infectious Disease (IMID) | Arm Label: OSS Phase 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Training and Supervision, Behavioral: Integrated Management of Infectious Disease (IMID) | Intervention Type: BEHAVIORAL; Name: Training and supervision; Assigned to Arm(s): OSS Phase 1 | Intervention Type: BEHAVIORAL; Name: Training and Supervision; Assigned to Arm(s): OSS Phase 2 | Intervention Type: BEHAVIORAL; Name: Integrated Management of Infectious Disease (IMID); Assigned to Arm(s): OSS Phase 1 | Intervention Type: BEHAVIORAL; Name: Integrated Management of Infectious Disease (IMID); Assigned to Arm(s): OSS Phase 2
D: Arm Label: Intervention; Type: OTHER; Interventions: Other: E-learning | Arm Label: Control; Type: OTHER; Interventions: Other: E-learning | Intervention Type: OTHER; Name: E-learning; Assigned to Arm(s): Control, Intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Advantages and Disadvantages of Long Term Sedation in ICU Patients
Brief Summary: The purpose of the study is to determine whether sedation of the critical ill patient prolongs the time receiving mechanical ventilation.


Options:
A: Arm Label: Dynamic light; Type: EXPERIMENTAL; Interventions: Other: Dynamic Light | Arm Label: Normal Light; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Dynamic Light; Assigned to Arm(s): Dynamic light
B: Arm Label: No sedatation intervention; Type: OTHER; Interventions: Procedure: Sedation or no sedation during mechanical ventilation | Intervention Type: PROCEDURE; Name: Sedation or no sedation during mechanical ventilation; Assigned to Arm(s): No sedatation intervention
C: Arm Label: PS; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Protocolized Sedation | Arm Label: PS + DI; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Protocolized sedation, with daily interruption | Intervention Type: PROCEDURE; Name: Protocolized Sedation; Assigned to Arm(s): PS | Intervention Type: PROCEDURE; Name: Protocolized sedation, with daily interruption; Assigned to Arm(s): PS + DI
D: Intervention Type: DRUG; Name: Arsenic trioxide; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Trisenox; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Advantages and Disadvantages of Long Term Sedation in ICU Patients
Brief Summary: The purpose of the study is to determine whether sedation of the critical ill patient prolongs the time receiving mechanical ventilation.


Options:
A: Arm Label: No sedatation intervention; Type: OTHER; Interventions: Procedure: Sedation or no sedation during mechanical ventilation | Intervention Type: PROCEDURE; Name: Sedation or no sedation during mechanical ventilation; Assigned to Arm(s): No sedatation intervention
B: N/A
C: Arm Label: Early PT OT; Type: EXPERIMENTAL; Interventions: Procedure: early PT OT | Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: early PT OT; Assigned to Arm(s): Early PT OT
D: Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care | Arm Label: Standardized Rehabilitation; Type: OTHER; Interventions: Other: Standardized Rehabilitation | Intervention Type: OTHER; Name: Standardized Rehabilitation; Assigned to Arm(s): Standardized Rehabilitation | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual Care

Answer: A